[Form 4] Enova International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 144 filing for MongoDB, Inc. (MDB) reports a planned sale of 2,000 common shares via Morgan Stanley Smith Barney. The transaction, valued at $500,000 (≈ $250 per share), is expected to occur on 31 Jul 2025 on the NASDAQ.

The company lists 81,714,313 shares outstanding, so the proposed sale represents only ~0.003 % of shares outstanding. All shares were obtained as restricted-stock grants between 2019-2021.

The filer—whose recent activity shows a 265-share sale for $54,603.25 on 2 Jul 2025—certifies that no undisclosed adverse information about MongoDB exists. No operational or earnings data accompany this notice; it solely concerns this secondary sale.

Insights

Securities Analyst

TL;DR: Small insider sale (0.003 % of float) disclosed; low market impact.

The Form 144 reveals a forthcoming divestiture of 2,000 MongoDB shares worth roughly $0.5 million. Relative to the 81.7 million shares outstanding, the sale is immaterial and falls well within routine Rule 144 clearances. Previous 265-share disposal further supports a gradual liquidity strategy. No information suggests corporate distress; the standard Rule 144 certification affirms absence of undisclosed negative news. Overall, I view the filing as routine and not price-moving.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Steven E

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO IL 60604

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.00001 per share	07/29/2025		M		22,872	A	$20.73	157,467	D
Common stock, par value $0.00001 per share	07/29/2025		S		22,872	D	$105.75(1)	134,595	D
Common stock, par value $0.00001 per share	07/29/2025		S		3,438	D	$105.5	131,157	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(2)(3)	$20.73	07/29/2025		M			22,872	(4)	02/11/2027	Common stock; par value $0.00001 per share	22,872	$0	22,872	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $105.50 to $106.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

4. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022 and February 11, 2023.

	/s/ Sean Rahilly, as attorney in fact	07/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MongoDB (MDB) shares are being registered for sale?

2,000 common shares are listed for potential sale under this Form 144.

What is the estimated value of the proposed sale?

The filing cites an aggregate market value of $500,000 for the 2,000 shares.

When is the anticipated sale date for the MDB shares?

The approximate sale date provided is July 31, 2025.

Who is the broker facilitating the transaction?

Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.

How many MongoDB shares are outstanding according to the filing?

The document lists 81,714,313 shares outstanding.

Were there any recent sales by the same filer?

Yes, 265 shares were sold on July 2, 2025 for $54,603.25.